Darifenacin, an M3 selective receptor antagonist, reduces the frequency of nocturnal awakening, an important symptom of overactive bladder

被引：5
|
作者：
Khullar, V
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37753-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [31] PHARMACOLOGICAL PROFILE OF DA-8010, A NOVEL BLADDER SELECTIVE MUSCARINIC RECEPTOR 3 ANTAGONIST FOR TREATMENT OF OVERACTIVE BLADDER
    Lee, Min Jung
    Moon, Jun-Hwan
    Park, Hyun-Min
    Lee, Hyung Keun
    Cho, Jong Hwan
    Choi, Sung Hak
    Im, Weonbin
    JOURNAL OF UROLOGY, 2016, 195 (04): : E416 - E417
  • [32] Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells
    Birder, L. A.
    Wolf-Johnston, A. S.
    Sun, Y.
    Chai, T. C.
    ACTA PHYSIOLOGICA, 2013, 207 (01) : 123 - 129
  • [33] An investigation of dose titration with darifenacin, an M3-selective receptor antagonist. (vol 95, pg 580, 2005)
    Steers, W
    Corcos, J
    Foote, J
    Kralidis, G
    BJU INTERNATIONAL, 2005, 95 (09) : 1385 - 1386
  • [34] A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Exerts Antidepressant-Like Effect in Mice
    Sun, Xiaojing
    Sun, Congcong
    Zhai, Lingyan
    Dong, Wei
    NEUROCHEMICAL RESEARCH, 2019, 44 (12) : 2723 - 2732
  • [35] A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Prevents Postischemic LTP: Involvement of NMDA Receptors
    Ma, Teng-Fei
    Zhou, Li
    Wang, Yun
    Qin, Shou-Jun
    Zhang, Yuan
    Hu, Bin
    Yan, Jing-Zhi
    Ma, Xing
    Zhou, Cheng-Hua
    Gu, Shu-Ling
    SYNAPSE, 2013, 67 (12) : 865 - 874
  • [36] A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Exerts Antidepressant-Like Effect in Mice
    Xiaojing Sun
    Congcong Sun
    Lingyan Zhai
    Wei Dong
    Neurochemical Research, 2019, 44 : 2723 - 2732
  • [37] The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double-blind, placebo-controlled phase 2 study
    Song, M.
    Kim, J. H.
    Lee, K. -S.
    Lee, J. Z.
    Oh, S. -J.
    Seo, J. T.
    Choi, J. B.
    Kim, S. W.
    Rhee, S. J.
    Choo, M. -S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (02) : 242 - 250
  • [38] EFFICACY AND SAFETY OF DA8010, A NOVEL M3 ANTAGONIST, IN PATIENTS WITH OVERACTIVE BLADDER: RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY
    Son, Hee Seo
    Kim, Joon Chul
    Kim, Hyeong Gon
    Shin, Dong Gil
    Lee, Kyu-Sung
    Yoo, Sangjun
    Ryu, Ho Young
    Choo, Myung-Soo
    Seo, Ju Tae
    Oh, Cheol Young
    Jeong, Seong Jin
    Moon, Hong Sang
    Kwon, Young-Nam
    Kim, Jang Hwan
    JOURNAL OF UROLOGY, 2021, 206 : E19 - E19
  • [39] Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
    Son, Hee Seo
    Oh, Cheol Young
    Choo, Myung-Soo
    Kim, Hyeong Gon
    Kim, Joon Chul
    Lee, Kyu-Sung
    Shin, Dong Gil
    Cho, Sung Yong
    Jeong, Seong Jin
    Seo, Ju Tae
    Yoon, Hana
    Moon, Hong Sang
    Kim, Jang Hwan
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2022, 26 (02) : 119 - 128
  • [40] Expression of muscarinic receptor subtypes in rat gastric smooth muscle - Effect of M3 selective antagonist on gastric motility and emptying
    Lin, S
    Kajimura, M
    Takeuchi, K
    Kodaira, M
    Hanai, H
    Kaneko, E
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (05) : 907 - 914
12345